biohaven: "rimegepant pivotal phase 3 trial results -- conference call.".
at least 9,000 rohingya were killed in rakhine state from august 25 to september 24, according to doctors without borders..
following close on aimovig's heels are three other drugs that target cgrp: fremanezumab, galcanezumab, and eptinezumab (which is given by iv)...
lea ament, left, and tamara nunley talk about the care their team provided for helen and robert valenzuela at st. jude medical center in fullerton. (scott smeltzer / staff photographer).